Clinical Trial Update: A Study of Iguratimod in Combination With Tofacitinib in RA Patients [Phase 4]

View source ↗

Summary

This entry reports a Phase 4 clinical trial evaluating iguratimod in combination with tofacitinib for rheumatoid arthritis, with recruitment not yet underway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Iguratimod (iguratimod)
• Tofacitinib (tofacitinib)

Snippet

Sponsor: Jie Chang | Conditions: Rheumatoid Arthritis (RA | Phase 4 | Status: NOT_YET_RECRUITING